Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: Is anti-HCV a risk factor?
Background and Rationale. Among the adverse events related to tuberculosis treatment, hepatotoxicity is the most serious, and recognition of risk factors for it is essential to achieve successful therapy. The aim of the study is to evaluate the role of anti-HCV as a risk factor for hepatotoxicity in...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2010-01-01
|
| coleção: | Annals of Hepatology |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1665268119316825 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|